LATE-BREAKING CLINICAL TRIALS | CORONARY II

Saturday, March 7, 2026

3:45 PM - 4:45 PM EST

Location: International Ballroom Center

Moderator(s)

Marc Cohen, MD

Chair of Medicine
Newark Beth Israel Med Ctr
Philadelphia, Pennsylvania, United States

Disclosure(s): BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Ongoing)
Stephen G. Ellis, MD, FACC, FSCAI

Director of Interventional Cardiology, Senior Academic Officer
Cleveland Clinic
Beachwood, Ohio, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Alexandre A. Abizaid, MD, PhD

Full Professor of Cardiology; Director of Invasive Cardiology
Incor
SÃO PAULO, Sao Paulo, Brazil

Disclosure information not submitted.
Tiziana Claudia Aranzulla, MD, MSc

Interventional cardiology
A.O. Ordine Mauriziano di Torino
Turin, Italy

Disclosure(s): No financial relationships to disclose
David Erlinge, MD, PhD

Professor, Consultant Interventional Cardiology
Lund University
Lund, Sweden

Disclosure(s): chiesi, bracco: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); kaminari, medical: Consulting Fees (e.g., advisory boards) (Ongoing)
Edward Koifman, MD

Senior interventional cardiologist
Wolfson Medical Center, and Tel Aviv University, Israel
Tel Aviv , Tel Aviv, Israel

Disclosure information not submitted.
Kenneth Rosenfield, MD, MHCDS

section head, vascular medicine and intervention
Massachusetts General Hospital
boston, Massachusetts, United States

Disclosure information not submitted.
Christian Spaulding, MD, PhD

Professor of Cardiology
European Hospital Georges Pompidou, Paris, France
Paris, France

Disclosure(s): Abbott, Asahi, BD, Boston Scientific, Conavi, Cook, Cordis, Endovascular Engineering, Evident Vascular, Gore, InfraRedx, Medtronic, Penumbra, Philips, RapidAI, Rampart IC, R3, Regeneron, Shockwave, Siemens, SoniVie, Teleflex, Terumo, Thrombolex, Vent: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Terminated, September 30, 2025); CERC: Grant/Research Support (Ongoing); Cordis, Endovascular Division: Consulting Fees (e.g., advisory boards) (Ongoing); Daiichi Sankyo, Boeringer Ingelheim , Sanofi, AstraZeneca , Chiesi, Bracco, Amgen, Novo Nordisk, Philips: Consulting Fees (e.g., advisory boards) (Terminated, June 30, 2025); French Ministry of Health: Grant/Research Support (Terminated, January 2, 2025); MedAlliance: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing); Novartis Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated, July 30, 2025); Techwald: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Valcare Medical: Consulting Fees (e.g., advisory boards) (Terminated, September 30, 2025)
On Topaz, MD

Professor of Medicine ,Duke University School of Medicine.
Duke University School of Medicine/Charles George VAMCCharles George Veterans Affairs MCCharles George Veterans Affairs MC
Biltmore Lake, North Carolina, United States

Disclosure(s): Angiodynamics/Auryon: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Alexander G. Truesdell, MD

Interventional Cardiology
Virginia Heart / Inova Schar Heart and Vascular
McLean, Virginia, United States

Disclosure(s): Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Getinge: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2024); Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)